Company Interviews

LIVETRADES interviews innovative, up and coming small cap companies

$VUZI | Vuzix Adds More Companies to VIP Program for M300 Smart Glasses
28 Jul
2016
Written by Mike Elliott

$VUZI | Vuzix Adds More Companies to VIP Program for M300 Smart Glasses »

Vuzix announced recently that they have added APX labs as well as Ubimax as the newest members to their Industrial Partner (VIP) program. APX labs has a host of leading companies as customers including boeing, GE, Tesla, Johnson and Johnson, Exxon Mobile and many others. Ubimax is a leading supplier for industrial wearable computing solutions.

Read more...
$NNDM | Nano Inks, Bioprinting & the Future of 3D Printers
26 Jul
2016
Written by Mike Elliott

$NNDM | Nano Inks, Bioprinting & the Future of 3D Printers »

Technology innovator, Nano Dimension, an emerging leader in 3D printing hardware, software and specialized inks lets CEOLIVE talk with their Head of Chemistry, Hila Elimelech, PhD.

Read more...
$VUZI | Vuzix Corp.’s Highly Anticipated AR Smart Glasses Begin Shipping
14 Jul
2016
Written by Mike Elliott

$VUZI | Vuzix Corp.’s Highly Anticipated AR Smart Glasses Begin Shipping »

As interest in augmented and virtual reality continues to grow, Vuzix Corp. (VUZI) has begun shipments of its newest innovation, the M300 Smart Glasses for hands free mobile computing.

Read more...
$NNDM | Nano Prepares 3D Printer for Human Tissue & Releases New 3D Printing Software
7 Jul
2016
Written by Mike Elliott

$NNDM | Nano Prepares 3D Printer for Human Tissue & Releases New 3D Printing Software »

In this episode of the CEOLIVE Investor Update Series we talk to Nano Dimension (NASDAQ: NNDM) CBO and Co-founder, Simon Fried about Nano's latest initiative to build a 3D Printer for stem cells and human tissue as well as the release of their "Switch" 3D Printing software.

Read more...
$INNV | An Undervalued Pharma Company with Strong Commercial Pipeline and Solid Revenues
21 Mar
2016
Written by Mike Elliott

$INNV | An Undervalued Pharma Company with Strong Commercial Pipeline and Solid Revenues »

In this episode of the CEOLIVE.TV Investor Profile Series we interview Dr. Bassam Damaj, CEO of Innovus Pharmaceuticals. Dr. Damaj discusses recent acquisitions, the company's strong commercial pipeline and why Innovus Pharmaceuticals (INNV) is undervalued right now.

Read more...
$CVM | Interview with CEO, Geert Kersten
12 Jan
2016
Written by Mike Elliott

$CVM | Interview with CEO, Geert Kersten »

In this episode of CEOLIVE.TV we talk to Geert Kersten, CEO of CEL-SCI Corp. (NYSE MKT: CVM) who discusses recent updates on the company's Phase 3 FDA Trials as well as what investors can expect for 2016.

Read more...

Login

Lost your password?